Mardia Samyoung Capillary Tubes: Q1 FY27 Unaudited Results & Office Shift Approved

Mardia Samyoung Capillary Tubes Company Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a Net Profit/(Loss) of ₹105.06 lakhs from continuing operations. Additionally, the Board of Directors has approved the shifting of the company’s corporate office to Ahmedabad, Gujarat, effective August 11, 2026.

Unaudited Financial Performance for Q1 FY27

Mardia Samyoung Capillary Tubes Company Limited has disclosed its unaudited financial results for the first quarter of the fiscal year 2027, ending on June 30, 2026. The company posted a Net Profit/(Loss) of ₹105.06 lakhs from continuing operations for the period. This figure represents a significant improvement compared to the preceding quarter’s result of ₹114.72 lakhs, but a decrease from the prior year’s comparable quarter which reported a loss of (₹22.88) lakhs. The total income for the quarter stood at ₹2483.91 lakhs.

Key Financial Highlights

The statement details revenue from operations at ₹2483.91 lakhs for the quarter ended June 30, 2026. Total expenses were recorded at ₹2341.91 lakhs. The Profit/(Loss) before exceptional and extraordinary items and tax for the period was ₹142.00 lakhs. After accounting for tax expenses of ₹36.92 lakhs, the net profit from continuing operations was ₹105.06 lakhs.

Corporate Office Relocation Approved

In a significant administrative update, the Board of Directors has also approved the relocation of the company’s corporate office. The move is scheduled to take place from its current premises at Shop-511 Pratik Mall, Near City Pulse Theatre, Kudasan, Gandhinagar, Gujarat, to a new office at Unit No. A-404, Titanium Square, S.G. Highway, Thaltej, Ahmedabad, Gujarat. This relocation will be effective from August 11, 2026.

Auditor’s Limited Review

The company’s statutory auditors, S K Bhavsar & Co., have conducted a limited review of the accompanying unaudited financial results as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. While the review found no material misstatements, the auditors noted limitations in verifying inventory, trade receivables, trade payables, and interest-free advances due to a lack of supporting documentation. Consequently, they could not provide assurance on the existence, valuation, or recoverability of these items.

Source: BSE

Previous Article

Gokaldas Exports: Q1 FY27 Income Up 21% to ₹1,180 Cr

Next Article

Manorama Industries: Clarifies Disclosure Delay for ₹20.64 Crore Customs Inquiry